Activity of the Heat Shock Protein 90 Inhibitor Ganetespib in Melanoma

Open Access

Peer-reviewed

Research Article

Xinqi Wu,

Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Melanoma Disease Center, Dana-Farber/Brigham and Women’s Cancer Center, Boston, Massachusetts, United States of America
⨯
Melina E. Marmarelis,

Affiliation Harvard Medical School, Boston, Massachusetts, United States of America
⨯
F. Stephen Hodi

* E-mail: stephen_hodi@dfci.harvard.edu

Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Melanoma Disease Center, Dana-Farber/Brigham and Women’s Cancer Center, Boston, Massachusetts, United States of America
⨯

Reader Comments (0)

Melanoma cells
Is the Subject Area "Melanoma cells" applicable to this article?

Thanks for your feedback.
Cell cycle and cell division
Is the Subject Area "Cell cycle and cell division" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Cyclins
Is the Subject Area "Cyclins" applicable to this article?

Thanks for your feedback.
Cutaneous melanoma
Is the Subject Area "Cutaneous melanoma" applicable to this article?

Thanks for your feedback.
Heat shock response
Is the Subject Area "Heat shock response" applicable to this article?

Thanks for your feedback.
Skin tumors
Is the Subject Area "Skin tumors" applicable to this article?

Thanks for your feedback.
Melanoma
Is the Subject Area "Melanoma" applicable to this article?

Thanks for your feedback.